Congratulations to Valetudo, a company named after the Roman goddess of health, who have been awarded our ANFF-C Gate 1 Investment. Just like their namesake, Valetudo plan to use red blood cells to treat disease, by creating drug capsules that can target their payload even to the brain. The team will use this investment to gather advice on their legal, regulatory and business requirements in order to take this technology to the next step.